Login to Your Account

Financings Roundup

Tuesday, September 25, 2012
• Pluristem Therapeutics Inc., of Haifa, Israel, said underwriters exercised in full their option to purchase 1.2 million more shares of common stock in a previously disclosed offering.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription